Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patients.
Victoria JacobsHeidi T MayTami L BairBrian G CrandallMichael J Cutler DOJohn D DayCharles MallenderJeffrey S OsbornJ Peter WeissThomas Jared BunchPublished in: Journal of cardiovascular electrophysiology (2017)
After catheter ablation, low risk patients do not benefit from long-term aspirin therapy, but are at risk for higher rates of bleeding when compared to no therapy or warfarin.
Keyphrases
- atrial fibrillation
- catheter ablation
- end stage renal disease
- left atrial
- ejection fraction
- newly diagnosed
- oral anticoagulants
- low dose
- left atrial appendage
- peritoneal dialysis
- heart failure
- type diabetes
- cardiovascular disease
- percutaneous coronary intervention
- cardiovascular events
- mesenchymal stem cells
- venous thromboembolism
- mitral valve
- subarachnoid hemorrhage
- left ventricular
- smoking cessation